NuVasive, Inc. (NASDAQ:NUVA)

Great top line growth potential. New focus on bottom line. Will covert market share to big profits in due time.

With an aging population growth in the medical device sector and in emerging markets will drive strong revenue growth.

This is a technological medical device company innovating at the forefront of minimally disruptive surgical products and procedures for the spine. With their surgical techniques and products, spine surgery patients have less blood loss, less time in hospital, and significantly quicker recovery time both initially after surgery and longer-term -- with patients typically going back to work within 4 - 6 weeks versus the more usual 6 months.

9/18/11 Options Predictor Rank #32. P/C Ratio 0.074 and Call Sizzle 3.794.

While this stock appears to be solid on the fundamentals, the company in 2009 issued over 60 M new shares (thanks for the dilution without any dividends), and this January, it just gave away nearly - yes, at a $0 acquisition - 150,000 shares to its officers. These officers don't appear to care about the stock price either. Checking at Yahoo Finance shows that the company's officers exercised their stock options, then sold them time after time from July 2009 though the present. Looking at their long-term stock values, they had steadily increasing value from January 2006 until July of 2008. After that, the stock become very volatile, and it just so happens to coincide with greedy management exercising and selling off their options. Until the company starts either buying back its shares or paying a dividend, this Fool is not interested.

This company is growing rapidly, has a strong market and a bright future. This is a bet that the pounding it just took is overdone. One BIG reservation that I have is the way that they give away stock options like candy at a Halloween party. Despite booking large losses in previous years they doled out multi-millions in stock based comp. This past quarter (Q3 2010) they wiped out half of net income with stock option related comp. Based on the pounding it's taken from the last earnings release (off over 45% from the highs) most options are now (fortunately for stockholders) underwater. I'm thinking about buying this one for real, but the way they treat their owners is giving me pause. Great product, great company, but waiting to see how they treat the owners. . .

Oh whatever... They are still making 50 million/year and growing; that is a price/EBITDA of 20. The margin on sales is 85%. If they cannot find buyers here, then they surely will elsewhere.

Longshots slipp'en and slid'en away,gett'en near over sold I do believe,only to see a better day the old fasion way . Did management say bankrupt,NO,not even close,but one would think so,as everyone flee's. One question? What day do they come back? Not sure,watch for the keys,but that they will indeed.

quality product, self marketing products, expanding into international markets.

Stock being hammered by short speculation and concerns over reimbursement. I think the concerns are overblown and this could be an easy double.

Rapid revenue growth in minimally invasive spine surgery

pt47, z1

bull

better tech and mkting force thans comps

As u can see in the stock trends, it is already higher then S&P 500 and it's going to keep outperforming S&P 500. Nuvasive has a product that everybody needs. Look at there sales and stock price in the past couples of yeear, they outperformed wall street prediction.

innovative product.

TM

Makes complete systems for minimally invasive spine fusion surgery. The older we get, the more likely we are to need such surgery. I think the stock is the next Intuitive Surgical (ISRG).

6.000